Are "deuterated psilocybin analogs" the future of psychedelic therapy?
November 6, 2023
More than half of patients in the clinical trial experienced improvement with ketamine.
June 6, 2023
Tryp Therapeutics is seeking approval from U.S. regulators for a clinical trial on psilocybin-assisted therapy to help those with irritable bowel syndrome (IBS).
May 26, 2023
U.K.-based Small Pharma is conducting a study of DMT and its potential for treating major depressive disorder.
January 30, 2023
Trial found “no serious adverse events were observed in either the MDMA group or the control group.”
January 12, 2023
Insomnia is often listed among the qualifying conditions to obtain a medical cannabis card.
December 27, 2022
A new study based in South Africa will examine how medical cannabis can help treat opioid addiction.
November 11, 2022
Participants will be allowed to take home psilocybin in a study examining its effects on depression and post-traumatic stress disorder.
November 2, 2022